Therapy Outcome Distribution
Therapy Objective Breakdown
Clinical Observations by Device
Clinical Observations by Quarter
100%
Success Rate
Total Observations
Critical Care Focus
Device 3880 Usage
Q4-2024 to Q3-2025 Clinical Performance Assessment
Maintain Excellence: Continue current clinical protocols to sustain the 100% success rate.
Capacity Planning: Prepare for Q4 demand surge through resource allocation.
Device Optimization: Leverage 3880 platform dominance for standardization while maintaining 3860 specialty capabilities.
Q4-2024 to Q3-2025 Clinical Performance Assessment
Success Rate:The existing data are sufficient to verify that the device is in conformity with all the essential requirements pertaining to clinical performance, clinical safety and undesirable side-effects as there were no statistically significant increases in the frequency or severity of complaints.
- 100% success rate demostrated a consistent clinical performance and proven reliability in diverse therapeutic scenarios.
- 100% success rate demostrated a consistent clinical performance and proven reliability in diverse therapeutic scenarios.